Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Generic Copaxone approval very unlikely this quarter, says Jefferies
The Fly on the Wall
Wednesday, May 28, 2014 - 9:24am
tags:
generics, Copaxone, Teva Pharmaceuticals, MS, multiple sclerosis
Sanofi to Sell Lilly Erection Drug Cialis Without Prescription
Bloomberg
Wednesday, May 28, 2014 - 9:22am
tags:
Sanofi, Cialis, erectile dysfunction, Eli Lilly, Cialis OTC
3 Biotech Stocks Falling Like a Knife: Aegerion, Insys, and Prothena
Motley Fool
Tuesday, May 27, 2014 - 9:51pm
tags:
Aegerion, Insys, Prothena
Arena To Present At Jefferies Conference - Is It A Catalyst?
Seeking Alpha
Tuesday, May 27, 2014 - 9:19pm
tags:
Arena Pharmaceuticals, obesity, Orexigen
Allergan investors want up to $200 per share from Valeant
Fierce Pharma
Tuesday, May 27, 2014 - 9:05pm
tags:
Valeant Pharmaceuticals, Allergan, M&A
Why Northwest Biotheraputics, Inc. Shares Were Flying High Today
Motley Fool
Tuesday, May 27, 2014 - 9:03pm
tags:
Northwest Biotherapeutics, DCVax
Pfizer and AstraZeneca: There Are No Winners Here
Motley Fool
Tuesday, May 27, 2014 - 9:02pm
tags:
Pfizer, AstraZeneca, M&A
GlaxoSmithKline says U.K. fraud office probing firm
Marketwatch
Tuesday, May 27, 2014 - 7:58pm
tags:
UK, fraud, GSK
Stay tuned for more drama in Pfizer-AstraZeneca saga, analysts say
Marketwatch
Tuesday, May 27, 2014 - 7:58pm
tags:
Pfizer, M&A, AstraZeneca
Recent Developments In Gilead's Non-Hepatitis C Programs
Seeking Alpha
Tuesday, May 27, 2014 - 11:55am
tags:
Gilead Sciences, RSV, GS-5806, Viread, TAF, Ranexa, atrial fibrillation
2nd Half Of 2014 Biotechnology Catalysts: Part 1
Seeking Alpha
Tuesday, May 27, 2014 - 11:53am
tags:
AcelRx, Anacor, BioDelivery Sciences, Eagle Pharmaceuticals, MannKind, Navidea Biopharmaceuticals, Orexigen, Omeros, EnteroMedics, Progenics, Trimel Pharmaceuticals
AstraZeneca Shares Fall After Pfizer Walks Away
FOX Business
Tuesday, May 27, 2014 - 11:49am
tags:
Pfizer, M&A, AstraZeneca
Six New FDA Regulations to be Introduced in 2014, Including Major Change in IND Reporting
Regulatory Focus
Tuesday, May 27, 2014 - 11:46am
tags:
FDA
Pfizer Ends AstraZeneca Deal Over Chinese Food, Sniping
Bloomberg
Tuesday, May 27, 2014 - 10:43am
tags:
Pfizer, M&A, AstraZeneca
Allergan criticises performance of Valeant's recent acquisitions
First Word Pharma
Tuesday, May 27, 2014 - 10:08am
tags:
Allergan, Valeant Pharmaceuticals, M&A
PhIII flop for top Boston cancer stem cell program batters Dainippon Sumitomo
Fierce Biotech
Tuesday, May 27, 2014 - 10:06am
tags:
stem cells, Dainippon Sumitomo, Boston Biomedical, BB1608, colorectal cancer
Verastem publishes data on targeting mesothelioma cancer stem cells
The Fly on the Wall
Tuesday, May 27, 2014 - 9:26am
tags:
Verastem, mesothelioma, stem cells
BioCryst's immune disorder drug succeeds in mid-stage trial
Yahoo/Reuters
Tuesday, May 27, 2014 - 9:24am
tags:
Biocryst, BCX4161, hereditary angiodema
Inovio subsidiary sells animal health assets
The Fly on the Wall
Tuesday, May 27, 2014 - 9:23am
tags:
Inovio, M&A, animal health, VGX Animal Health, Korea
Pfizer launches OTC Nexium 24HR
The Fly on the Wall
Tuesday, May 27, 2014 - 9:21am
tags:
Nexium, OTC, Pfizer, Nexium 24HR

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.